These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38128937)

  • 1. Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.
    Tesfaye W; Krass I; Sud K; Johnson DW; Van C; Versace VL; McMorrow R; Fethney J; Mullan J; Tran A; Robson B; Vagholkar S; Kairaitis L; Gisev N; Fathima M; Tong V; Coric N; Castelino RL
    BMJ Open; 2023 Dec; 13(12):e079110. PubMed ID: 38128937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
    BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.
    Logan B; Viecelli AK; Johnson DW; Aquino EM; Bailey J; Comans TA; Gray LC; Hawley CM; Hickey LE; Janda M; Jaure A; Jose MD; Kalaw E; Kiriwandeniya C; Matsuyama M; Mihala G; Nguyen KH; Pascoe E; Pole JD; Polkinghorne KR; Pond D; Raj R; Reidlinger DM; Scholes-Robertson N; Varghese J; Wong G; Hubbard RE;
    Trials; 2023 May; 24(1):365. PubMed ID: 37254217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging the gap between physical and mental illness in community pharmacy (
    Wheeler AJ; O'Reilly CL; El-Den S; Byrnes J; Ware RS; McMillan SS
    BMJ Open; 2020 Jul; 10(7):e039983. PubMed ID: 32709657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
    Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
    JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Byrne C; Radley A; Inglis SK; Beer LJZ; Palmer N; Pham MD; Healy B; Doyle JS; Donnan P; Dillon JF
    BMJ Open; 2020 Aug; 10(8):e036501. PubMed ID: 32868356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding community pharmacists' scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE).
    Mazza D; Assifi AR; Hussainy SY; Bateson D; Johnston S; Tomnay J; Kasza J; Church J; Grzeskowiak LE; Nissen L; Cameron ST
    BMJ Open; 2023 Aug; 13(8):e073154. PubMed ID: 37652588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimisation of dialysis risk in hospital patients with chronic kidney disease (MinDial): study protocol for a multicentre, stepped-wedge, cluster-randomised controlled trial.
    Stelzer D; Binder H; Glattacker M; Graf E; Hahn M; Hollenbeck M; Kaier K; Kowall B; Kuklik N; Metzner G; Mueller N; Seiler L; Stolpe S; Blume C
    Trials; 2024 Jun; 25(1):368. PubMed ID: 38849916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a chronic kidney disease risk assessment service in community pharmacies.
    Gheewala PA; Peterson GM; Zaidi STR; Jose MD; Castelino RL
    Nephrology (Carlton); 2019 Mar; 24(3):301-307. PubMed ID: 29493051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: a study protocol for a pragmatic cluster randomised trial.
    Radley A; de Bruin M; Inglis SK; Donnan PT; Dillon JF
    BMJ Open; 2018 Dec; 8(12):e021443. PubMed ID: 30552244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand.
    Shortt G; Shortt N; Bird G; Kerse K; Lieffering N; Martin A; Eathorne A; Black B; Kim B; Rademaker M; Reiche L; Paa ST; Harding S; Armour M; Semprini A
    BMC Complement Med Ther; 2024 Jan; 24(1):61. PubMed ID: 38287323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
    Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
    Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.
    Escribá-Martí G; Cámara-Ramos I; Climent-Catalá MT; Escudero-Quesada V; Salar-Ibáñez L
    PLoS One; 2022; 17(12):e0278648. PubMed ID: 36548299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans.
    Peralta CA; Frigaard M; Rubinsky AD; Rolon L; Lo L; Voora S; Seal K; Tuot D; Chao S; Lui K; Chiao P; Powe N; Shlipak M
    BMC Nephrol; 2017 Apr; 18(1):132. PubMed ID: 28399844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial.
    Peralta CA; Livaudais-Toman J; Stebbins M; Lo L; Robinson A; Pathak S; Scherzer R; Karliner LS
    Am J Kidney Dis; 2020 Nov; 76(5):636-644. PubMed ID: 32682696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent intervention to improve blood pressure management in chronic kidney disease: a protocol for a pragmatic clinical trial.
    Kilgallon JL; Gannon M; Burns Z; McMahon G; Dykes P; Linder J; Bates DW; Waikar S; Lipsitz S; Baer HJ; Samal L
    BMJ Open; 2021 Dec; 11(12):e054065. PubMed ID: 34937722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.